U.S. flag

An official website of the United States government

NM_000233.4(LHCGR):c.1635C>A (p.Cys545Ter) AND Leydig cell agenesis

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Jan 3, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000015469.28

Allele description [Variation Report for NM_000233.4(LHCGR):c.1635C>A (p.Cys545Ter)]

NM_000233.4(LHCGR):c.1635C>A (p.Cys545Ter)

Genes:
STON1-GTF2A1L:STON1-GTF2A1L readthrough [Gene - HGNC]
LHCGR:luteinizing hormone/choriogonadotropin receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p16.3
Genomic location:
Preferred name:
NM_000233.4(LHCGR):c.1635C>A (p.Cys545Ter)
HGVS:
  • NC_000002.12:g.48688162G>T
  • NG_008193.2:g.72580C>A
  • NG_033050.2:g.163238G>T
  • NM_000233.4:c.1635C>AMANE SELECT
  • NM_001198593.2:c.3441+16482G>T
  • NP_000224.2:p.Cys545Ter
  • NC_000002.11:g.48915301G>T
  • NM_000233.3:c.1635C>A
Protein change:
C545*; CYS545TER
Links:
OMIM: 152790.0007; dbSNP: rs121912523
NCBI 1000 Genomes Browser:
rs121912523
Molecular consequence:
  • NM_001198593.2:c.3441+16482G>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000233.4:c.1635C>A - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Leydig cell agenesis
Synonyms:
LEYDIG CELL HYPOPLASIA WITH MALE PSEUDOHERMAPHRODITISM; LEYDIG CELL HYPOPLASIA, COMPLETE; HYPERGONADOTROPIC HYPOGONADISM, MALE, DUE TO LHCGR DEFECT; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009384; MedGen: C0266432; OMIM: 238320

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000035734OMIM
no assertion criteria provided
Pathogenic
(Nov 1, 1998)
germlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

SCV000692110Clinical Molecular Genetics Laboratory, Johns Hopkins All Children's Hospital
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jan 3, 2018)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A nonsense mutation of the human luteinizing hormone receptor gene in Leydig cell hypoplasia.

Laue L, Wu SM, Kudo M, Hsueh AJ, Cutler GB Jr, Griffin JE, Wilson JD, Brain C, Berry AC, Grant DB, et al.

Hum Mol Genet. 1995 Aug;4(8):1429-33.

PubMed [citation]
PMID:
7581384

Inactivation of the luteinizing hormone/chorionic gonadotropin receptor by an insertional mutation in Leydig cell hypoplasia.

Wu SM, Hallermeier KM, Laue L, Brain C, Berry AC, Grant DB, Griffin JE, Wilson JD, Cutler GB Jr, Chan WY.

Mol Endocrinol. 1998 Nov;12(11):1651-60.

PubMed [citation]
PMID:
9817592
See all PubMed Citations (3)

Details of each submission

From OMIM, SCV000035734.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)

Description

Laue et al. (1995) identified a cys545-to-ter mutation in exon 11 of the LHCGR gene in 2 46,XY sibs with male pseudohermaphroditism (238320). The mutation was an A-to-C transversion at nucleotide 1635 which caused loss of function of the receptor by introducing a stop codon at residue 545 in transmembrane helix 5 of the luteinizing hormone receptor. Surface expression of the truncated gene product in human embryonic kidney cells stably transfected with cDNA encoding the mutant protein was diminished compared to the wildtype gene, and hCG-induced cAMP accumulation was impaired. The mutation in the 2 sibs was present also in the normal father and was not present in the mother. The finding excludes the possibility of a dominant-negative mutation in the sisters and suggests that they are compound heterozygotes, the mutation inherited from the mother not being identified. The results of Laue et al. (1995) indicated that functional domains between transmembrane helix 5 and the C-terminal cytoplasmic tail of the gene are required for normal cell surface expression of the receptor and signal transduction. In the family reported by Laue et al. (1995), Wu et al. (1998) identified a loss of function mutation in the mother (152790.0021).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Clinical Molecular Genetics Laboratory, Johns Hopkins All Children's Hospital, SCV000692110.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024